Dhanusha Sabanathan

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring

Dhanusha Sabanathan, Alison Y. Zhang, Peter Fox et al. · Cancer Chemotherapy and Pharmacology · 2017 · 30 citations

Therapeutic Drug Monitoring, Urology, Oncology +9

209P Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors

Samuel J. Klempner, M. Beeram, Dhanusha Sabanathan et al. · Annals of Oncology · 2021 · 26 citations

Sbt6050 Monotherapy, Medicine, Immunology +7

Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982–2011

Marina T. van Leeuwen, Howard Gurney, Jennifer Turner et al. · Cancer Epidemiology · 2016 · 15 citations · Full text

Cancer Epidemiology, Malignant Disease, Medicine +11

Safety and efficacy of DB-1303 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase 1/2a study.

Kathleen N. Moore, Dhanusha Sabanathan, Yiqun Du et al. · Journal of Clinical Oncology · 2023 · 14 citations

Her2 –, Cancer Management, Immunology +17

382MO Updated results from the phase I/II study of OP-1250, an oral complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD) in patients (pts) with advanced or metastatic ER-positive, HER2-negative breast cancer

Nancy U. Lin, Virginia F. Borges, Manish R. Patel et al. · Annals of Oncology · 2023 · 14 citations · Full text

Endocrine Oncology, Breast Oncology, Phase I/ii Study +12